🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5 results for “Sionna” Clear

  1. Polyamide HD membrane

    Sionna Therapeutics

    End-stage Kidney Disease

    phase 3 other active

    1 trial

  2. pad-gauze with tranexamic acid (Hemostopan™)

    Sionna Therapeutics

    Bleeding

    phase 3 other active

    1 trial

  3. SION-719

    Sionna Therapeutics

    Cystic Fibrosis (CF)

    phase 2 small molecule active

    1 trial

  4. SION-451

    Sionna Therapeutics

    Cystic Fibrosis (CF)

    phase 1 small molecule active

    1 trial

  5. blood draw from three different vessels

    Sionna Therapeutics

    Accidental Hypothermia

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources